Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Research Grade Cemavafusp | Login | Research Grade Cemavafusp | ||||||||||||||||
|
||||||||||||||||||
Research Grade Sotiburafusp Alfa | Login | Research Grade Sotiburafusp Alfa | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human CD371/CLEC12A Antibody (H6e7) | Login | Research Grade Anti-Human CD371/CLEC12A Antibody (H6e7) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human DLL4 Antibody (MLCK-2ABL-001) | Login | Research Grade Anti-Human DLL4 Antibody (MLCK-2ABL-001) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Verekitug | Login | Research Grade Verekitug | ||||||||||||||||
|
||||||||||||||||||
Research Grade Zalfermin | Login | Research Grade Zalfermin | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Dog CD152/CTLA4 Antibody (12B3) | Login | Research Grade Anti-Dog CD152/CTLA4 Antibody (12B3) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Dog CD152/CTLA4 Antibody (39A11) | Login | Research Grade Anti-Dog CD152/CTLA4 Antibody (39A11) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human TSLPR Antibody (RG-7258) | Login | Research Grade Anti-Human TSLPR Antibody (RG-7258) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Efruxifermin | Login | Research Grade Efruxifermin | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-HIV1 gp120/Glycoprotein 120 Antibody (mD1.22) | Login | Research Grade Anti-HIV1 gp120/Glycoprotein 120 Antibody (mD1.22) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Aldastotug | Login | Research Grade Aldastotug | ||||||||||||||||
|
||||||||||||||||||
Research Grade Donitabart | Login | Research Grade Donitabart | ||||||||||||||||
|
||||||||||||||||||
Research Grade Gocatamig | Login | Research Grade Gocatamig | ||||||||||||||||
|
||||||||||||||||||
Research Grade Obrixtamig | Login | Research Grade Obrixtamig | ||||||||||||||||
|
||||||||||||||||||
Research Grade Efimosfermin Alfa | Login | Research Grade Efimosfermin Alfa | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human DLL3 & CD47/MER6 Antibody (PT-217) | Login | Research Grade Anti-Human DLL3 & CD47/MER6 Antibody (PT-217) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Anti-Human DLL3 & CD3E & Albumin/HSA Trispecific Antibody (HPN328) | Login | Research Grade Anti-Human DLL3 & CD3E & Albumin/HSA Trispecific Antibody (HPN328) | ||||||||||||||||
|
||||||||||||||||||
Sirtratumab vedotin (ADC) | Login | Sirtratumab vedotin (ADC) | ||||||||||||||||
|
||||||||||||||||||
Research Grade Lerdelimumab | Login | Research Grade Lerdelimumab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Urabrelimab | Login | Research Grade Urabrelimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Gatralimab | Login | Research Grade Gatralimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Besilesomab | Login | Research Grade Besilesomab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Tinurilimab | Login | Research Grade Tinurilimab | ||||||||||||||||
|
||||||||||||||||||
Research Grade Lemalesomab | Login | Research Grade Lemalesomab | ||||||||||||||||
|